Esposito Pamela bought KYMR
May 19, 2026 · Form 4 insider transaction
Esposito Pamela bought 1,000 shares of Kymera Therapeutics, Inc. at $31.20 per share, a transaction worth $31.2K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,000
Price
$31.20
Total value
$31.2K
InsiderEsposito Pamela
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMay 19, 2026
Filing dateMay 19, 2026
Shares owned after1,000
OwnershipDirect
10b5-1 planNo
AmendedNo